Updated:
Zhuzhou Qianjin Pharmaceutical
Zhuzhou Qianjin Pharmaceutical was founded in 1966 in Zhuzhou, Hunan province, and has since grown into a vertically integrated enterprise spanning the...
Zhuzhou Qianjin Pharmaceutical
Zhuzhou Qianjin Pharmaceutical was founded in 1966 in Zhuzhou, Hunan province, and has since grown into a vertically integrated enterprise spanning the manufacturing, wholesale, and retail of Chinese patent medicines and pharmaceuticals. Shun Jian serves as Chairman of the Board, while Zhiyong Chen operates as General Manager and Director. The firm also holds a recognized heritage status, receiving the 'Hunan Time-Honored Brand' designation in 2018 for its enduring regional presence. The firm's investment posture is inseparable from its operational one: it directly deploys capital into planting bases for crude Chinese drugs, a wholesale distribution network, and retail pharmacies that sell its own manufactured products. Its asset base includes the industrial headquarters at No. 801 Zhuzhou Avenue and a mixed-use cultural square, Qianjin Wenhua Guangchang, in Zhuzhou. Major institutional shareholder China Merchants Fund Management Co., Ltd. adds a linkage to broader state-owned financial infrastructure. The corporate investment activity flows through the firm's own balance sheet, with operations concentrated in Hunan province and serving the broader Chinese market. No separate venture fund, family office, or private equity vehicle is publicly recorded. The firm participates actively in national pharmaceutical standards and exchanges via the Chinese Pharmaceutical Association. Former Chairman Jiang Duanyu was recognized nationally as an Outstanding Entrepreneur, underscoring the firm's historical prominence in China's industrial pharmaceutical landscape. Unlike most corporate investors that spray cash across venture portfolios, Zhuzhou Qianjin Pharmaceutical's deployment follows an operating-company mandate: every investment ties back to its proprietary medicine pipeline, planting base, or distribution channel. That makes it a pure-play commercial extension of a state-anchored manufacturing enterprise rather than a diversified allocator.
General information
Firm type
Corporate Investor
Year founded
1966
Location
Region
Asia
Country
China
City
Zhuzhou
Corporate office
No. 801 Zhuzhou Avenue, Tianyuan District, Zhuzhou, Hunan, China
Principals
Shun Jian
Chairman of the Board and Legal Representative
Zhiyong Chen
General Manager and Director
Sector focus
Frequently asked questions
Who runs investment decisions at Zhuzhou Qianjin Pharmaceutical?
Chairman Shun Jian holds ultimate authority as Legal Representative and Chairman of the Board. General Manager Zhiyong Chen manages day-to-day operational execution. All investment decisions appear to flow through the corporate structure rather than through a separately managed investment committee or external advisor.
How does Zhuzhou Qianjin Pharmaceutical source its investment opportunities?
The firm sources investments entirely through its core operating business — expanding its own crude drug planting bases, wholesale distribution channels, and retail pharmacy locations. It does not operate a venture-style scouting function or participate in third-party deal syndication based on public record.
Is Zhuzhou Qianjin Pharmaceutical a family office or a corporate investor?
It is a corporate investor. It deploys the industrial balance sheet of a pharmaceutical manufacturer rather than managing private wealth for a family. There is no evidence of a separate family office structure or private investment vehicle.
Does Zhuzhou Qianjin Pharmaceutical take outside capital or co-invest alongside external partners?
The firm does not take external limited partner capital. China Merchants Fund Management holds a major institutional stake, indicating that external capital participates at the parent equity level, but Zhuzhou Qianjin itself deploys only its own operational balance sheet.
What is Zhuzhou Qianjin Pharmaceutical's geographic investment focus?
All known physical assets and operations, including its headquarters, manufacturing, and the Qianjin Wenhua Guangchang mixed-use property, are located in Zhuzhou, Hunan province. Its commercial footprint serves the Chinese domestic market for Chinese patent medicines and pharmaceuticals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: